Answer
In an interaction study in healthy subjects, co-administered erythromycin did not affect the efficacy or pharmacokinetics of gadoxetate disodium (Primovist).
Sources for this answer
- Gadoxetate disodium 0.25 mmol/ml, solution for injection, prefilled syringeBayer plc · emc · SmPC §4.5 Interaction with other medicinal products · Version 20Document updated
Sources checked